1. Home
  2. companies
  3. Cubist Pharmaceuticals

Cubist Pharmaceuticals

Merck Completes Tender Offer to Acquire Cubist
Merck Completes Tender Offer to Acquire Cubist
Yahoo
Merck
M&A
Cubist Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
4 Potential Blockbuster Drugs The FDA Just Approved
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
Year in review: The biggest stories in biotech in 2014
Year in review: The biggest stories in biotech in 2014
Bizjournals.com
biotech
Merck
M&A
Cubist Pharmaceuticals
Idenix
Covidien
Medtronic
Gilead Sciences
Shire
AbbVie
drug pricing
FDA approves Cubists' drug for antibiotic-resistant bacteria
FDA approves Cubists' drug for antibiotic-resistant bacteria
Yahoo/Reuters
Cubist Pharmaceuticals
Zerbaxa
antibiotics
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Motley Fool
Cubist Pharmaceuticals
Sivextro
Cubicin
anti-infectives
Zerbaxa
Cubist extends superbug R&D to Europe
Cubist extends superbug R&D to Europe
Pharmaphorum
Cubist Pharmaceuticals
Europe
R&D
antibiotics
antibiotic resistance
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A
Bloomberg
JNJ
M&A
Cubist Pharmaceuticals
antibiotics
superbugs
Investing to Fight Toilet and Elevator Superbugs
Investing to Fight Toilet and Elevator Superbugs
Motley Fool
Durata Therapeutics
Cubist Pharmaceuticals
3 Biotech Stocks with Jaw-Dropping Growth Potential
3 Biotech Stocks with Jaw-Dropping Growth Potential
Motley Fool
Cubist Pharmaceuticals
NPS Pharmaceuticals
Flamel
Cubist and Durata Heat Up Antibiotic Market
Cubist and Durata Heat Up Antibiotic Market
Motley Fool
Cubist Pharmaceuticals
Durata Therapeutics
antibiotics
Dalvance
Sivextro
ceftolozane/tazobactam
Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
The Fly on the Wall
Sivextro
antibiotics
Cubist Pharmaceuticals
FDA approves Cubist drug to treat acute skin infections
FDA approves Cubist drug to treat acute skin infections
Yahoo/Reuters
FDA
Cubist Pharmaceuticals
antibiotics
Sivextro
As Antibiotics Stop Working, Five Biotechs Seek Cures
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
Cubist Readies For Takeoff With New Antibiotic Launch
Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com
antibiotics
Cubist Pharmaceuticals
Sivextro
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Superbug Researchers Wait on Future of AstraZeneca Drugs
Superbug Researchers Wait on Future of AstraZeneca Drugs
Bloomberg
AstraZeneca
Pfizer
superbugs
antibiotics
Cubist Pharmaceuticals
drug-resistant bacteria
Cubist gram-negative antibiotic data supports approval, says JMP Securities
Cubist gram-negative antibiotic data supports approval, says JMP Securities
The Fly on the Wall
Cubist Pharmaceuticals
antibiotics
gram-negative bacteria
Pfizer Blockbuster Zyvox Under Attack
Pfizer Blockbuster Zyvox Under Attack
Motley Fool
Pfizer
Zyvox
Durata Therapeutics
Cubist Pharmaceuticals
antibiotics
FDA panel says Cubist anti-infective shows efficacy, safety
FDA panel says Cubist anti-infective shows efficacy, safety
Yahoo/Reuters
FDA
Cubist Pharmaceuticals
antibiotics
tedizolid

Click here to subscribe to daily news headlines in your email inbox